BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 96 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $45,517 | -60.6% | 17,991 | +3.8% | 0.00% | -63.6% |
Q2 2023 | $115,385 | -64.3% | 17,325 | 0.0% | 0.01% | -71.1% |
Q1 2023 | $323,285 | +10.0% | 17,325 | +23.1% | 0.04% | +18.8% |
Q1 2022 | $294,000 | +2.8% | 14,075 | 0.0% | 0.03% | -5.9% |
Q4 2021 | $286,000 | -41.8% | 14,075 | -13.0% | 0.03% | -45.2% |
Q3 2021 | $491,000 | +2.9% | 16,175 | -1.5% | 0.06% | +3.3% |
Q2 2021 | $477,000 | -33.4% | 16,425 | -1.1% | 0.06% | -40.6% |
Q1 2021 | $716,000 | -1.9% | 16,600 | +5.1% | 0.10% | -6.5% |
Q4 2020 | $730,000 | +23.7% | 15,800 | +16.2% | 0.11% | -2.7% |
Q3 2020 | $590,000 | -16.3% | 13,600 | +2.3% | 0.11% | -22.4% |
Q2 2020 | $705,000 | +120.3% | 13,300 | -7.0% | 0.14% | +83.3% |
Q1 2020 | $320,000 | +814.3% | 14,300 | +186.0% | 0.08% | +680.0% |
Q3 2019 | $35,000 | -34.0% | 5,000 | 0.0% | 0.01% | -37.5% |
Q2 2019 | $53,000 | – | 5,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |